Catalya is a drug formulation CRO relying on a synthetic polymer platform technology
developed by Prof. Christian Grandfils (CEIB,
Catalya’s PolyAmphiphilic Complexes (PAC)
have demonstrated their wide range of
efficacy for the solubilization, stability and deliverance of biopharmaceutical and chemical entities.
Share your drugs solubility, stability and delivery challenges today with us to catalyze your success of tomorrow